MEETING REPORT: THE ALPHA PROJECT: A STAKEHOLDER MEETING ON LUPUS CLINICAL TRIAL OUTCOME MEASURES AND THE PATIENT PERSPECTIVE

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

Drug development in lupus has improved over the past 10 years but still lags behind that of other rheumatic disease areas.Assessment of prospective lupus therapies in clinical trials has proved challenging for reasons that are multifactorial including the heterogeneity of the disease, study design limitations and a lack of validated biomarkers whic

read more



Nxf7 deficiency impairs social exploration and spatio-cognitive abilities as well as hippocampal synaptic plasticity in mice

Nuclear RNA export factors (NXF) are conserved in all metazoans and are deemed essential for shuttling RNA across the nuclear envelope and other post-transcriptional processes (such as mRNA metabolism, storage and stability).Disruption of human NXF5 has been implicated in intellectual and Interface Board psychosocial disabilities.In the present rep

read more